Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/26/1999CA2263703A1 A process for producing enteric coated pancreatin granules
08/25/1999EP0937982A2 Diagnostic and therapeutic agent for treatment of autoimmune hepatitis
08/25/1999EP0937777A2 GABA receptors and their uses
08/25/1999EP0937734A1 11-Acetyl-12,13-dioxabicyclo [8.2.1] tridecenone derivatives, process for making them and pharmaceutical compositions containing them
08/25/1999EP0937726A1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
08/25/1999EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors
08/25/1999EP0937718A1 Antibiotic tkr2648 and process for producing the same
08/25/1999EP0937708A2 sulphonamide derivatives
08/25/1999EP0937464A2 Combined pharmaceutical preparation containing inhibitors of the sodium hydrogen exchange and a medicament for the treatment of cardiovascular diseases
08/25/1999EP0937460A2 Use of an antidiarrheal for the manufacture of a medicament for the treatment of inflammatory conditions
08/25/1999EP0937459A2 Pharmaceutical compositions for the treatment of ischemic brain damage
08/25/1999EP0937458A2 Pyrrolidine and piperidine derivatives
08/25/1999EP0937457A1 Remedies for allergic dermatitis
08/25/1999EP0937395A1 Disinfecting and sterilizing concentrate containing an aromatic dialdehyde and a neutral ph buffering system
08/25/1999EP0937394A1 Antimicrobial composition
08/25/1999EP0937153A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
08/25/1999EP0937150A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
08/25/1999EP0937148A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
08/25/1999EP0937102A1 Human monocyte chemotactic proprotein
08/25/1999EP0937100A1 A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof
08/25/1999EP0937099A1 Oligomers which inhibit the expression of interleukin genes
08/25/1999EP0937093A2 1-galactose derivatives
08/25/1999EP0937092A1 Solid support matrices containing a toxin binding oligosaccharide
08/25/1999EP0937089A1 New knoevenagel condensation products, method for their production and their use
08/25/1999EP0937085A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same
08/25/1999EP0937084A1 Process for the preparation of salts and esters of clavulanic acid
08/25/1999EP0937083A1 A crystalline substance of cefditoren pivoxyl and the production of the same
08/25/1999EP0937079A1 Stabilized carbapenem antibiotic compositions and method of making
08/25/1999EP0937078A1 Tricyclic carbapenem compounds
08/25/1999EP0937077A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
08/25/1999EP0937076A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
08/25/1999EP0937075A1 New imidazopyridines and oxazolopyridines
08/25/1999EP0937074A1 Benzonaphthyridines as bronchial therapeutics
08/25/1999EP0937072A1 THIENYLCYCLOHEXANONE DERIVATIVES AS LIGANDS OF THE GABA A? $g(a)5 RECEPTOR SUBTYPE
08/25/1999EP0937071A1 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
08/25/1999EP0937070A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
08/25/1999EP0937069A1 Piperazino derivatives as neurokinin antagonists
08/25/1999EP0937067A1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
08/25/1999EP0937066A1 (4r,5s,6s,7r)-hexahydro-1- 5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis phenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor
08/25/1999EP0937065A1 Constrained somatostatin agonists and antagonists
08/25/1999EP0937064A1 Substituted oximes derivatives useful as neurokinin antagonists
08/25/1999EP0937063A1 Aryloxypropanolamine derivatives, method of preparation and applications thereof
08/25/1999EP0937062A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937061A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937060A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937059A1 NOVEL $i(TRANS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937058A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937057A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
08/25/1999EP0937054A1 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications
08/25/1999EP0937053A1 Sustained-release derivatives of hydroxylated analogs of substituted 1- 2 bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake
08/25/1999EP0937048A1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa
08/25/1999EP0937047A1 1-arylphthalazine antagonists of excitatory amino acid receptors
08/25/1999EP0937046A2 Substituted 3-benzylpyrazoles and their use as herbicides and for lowering the sugar content in blood
08/25/1999EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
08/25/1999EP0937044A1 Cftr channel activator compounds and pharmaceutical compositions containing same
08/25/1999EP0937043A1 Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
08/25/1999EP0937042A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors
08/25/1999EP0937041A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments
08/25/1999EP0937040A2 N-substituted 2-cyanopyrrolidines
08/25/1999EP0937038A1 Vitamin d analogues
08/25/1999EP0937037A1 Sodium salt of poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof
08/25/1999EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
08/25/1999EP0937035A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
08/25/1999EP0937032A1 Substituted gamma aminobutyric acids as pharmaceutical agents
08/25/1999EP0937030A1 3-amino-propoxyphenyl derivatives (i)
08/25/1999EP0936924A2 Pharmaceutical composition containing a 5ht 2c? antagonist and a d 2? antagonist
08/25/1999EP0936916A1 Cosmetic compositions
08/25/1999EP0936915A1 Chelating agents and their metal chelates for treating free radicals induced conditions
08/25/1999EP0936914A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors
08/25/1999EP0936913A1 Oral pharmaceutical preparation containing ibandronat
08/25/1999EP0936912A1 Inhibitors of cysteine protease
08/25/1999EP0936911A1 Adenosine deaminase inhibitors
08/25/1999EP0936910A2 Intracoronary stents containing quinazolinone derivatives
08/25/1999EP0936909A1 Pharmaceutical composition for treating viral diseases
08/25/1999EP0936908A1 Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als)
08/25/1999EP0936907A2 Pharmaceutical preparation
08/25/1999EP0936906A1 Reflux inhibitors
08/25/1999EP0936902A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
08/25/1999EP0936901A1 Pharmaceutical composition for rapid suspension in aqueous media
08/25/1999EP0936900A2 Aqueous, antimicrobial liquid cleaning formulation
08/25/1999EP0936897A1 Composition having tanning and sun-screening activity, and cosmetic uses thereof
08/25/1999EP0936896A1 Cosmetic compositions
08/25/1999EP0936866A1 Compounds, compositions and methods for treating antibiotic-resistant infections
08/25/1999EP0921774A4 Transdermal drug delivery matrix for coadministering estradiol and another steroid
08/25/1999EP0839036B1 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
08/25/1999EP0751934B1 Substituted azetidinone compounds useful as hypocholesterolemic agents
08/25/1999EP0749430B1 Thiazolidinedione derivatives as anti-hyperglycemic agents
08/25/1999EP0723451B1 Use of lithium compounds in combination with ace-inhibitors and/or angiotensin ii -receptor antagonist for treating high blood pressure
08/25/1999EP0700290B1 Rectal compositions containing odansetron in its free base form
08/25/1999EP0667858B1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
08/25/1999EP0661967B1 Combined virustatic antimediator (covam) treatment of common colds
08/25/1999EP0650483B1 (3R,4R)-$g(D)?6 -TETRAHYDROCANNABINOL-7-OIC ACIDS
08/25/1999EP0612321B1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity
08/25/1999EP0572494B1 Composition for use in transdermal administration
08/25/1999EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor
08/25/1999CN1226933A Method for preparing polydispersed saccharide composition and resulting polydispersed saccharide composition
08/25/1999CN1226927A Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
08/25/1999CN1226899A Synthetic IL-10 analogues
08/25/1999CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof
08/25/1999CN1226893A Selected derivatives of K-252a